204 related articles for article (PubMed ID: 17893232)
21. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
[TBL] [Abstract][Full Text] [Related]
22. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
[TBL] [Abstract][Full Text] [Related]
23. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.
Peters JM; Hollingshead HE; Gonzalez FJ
Clin Sci (Lond); 2008 Aug; 115(4):107-27. PubMed ID: 18616431
[TBL] [Abstract][Full Text] [Related]
24. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
25. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
26. PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism.
Hollingshead HE; Morimura K; Adachi M; Kennett MJ; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Dig Dis Sci; 2007 Nov; 52(11):2912-9. PubMed ID: 17404849
[TBL] [Abstract][Full Text] [Related]
27. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
28. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
29. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.
Peters JM; Foreman JE; Gonzalez FJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):619-40. PubMed ID: 22037942
[TBL] [Abstract][Full Text] [Related]
30. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
[TBL] [Abstract][Full Text] [Related]
33. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
Kohno H; Suzuki R; Sugie S; Tanaka T
BMC Cancer; 2005 May; 5():46. PubMed ID: 15892897
[TBL] [Abstract][Full Text] [Related]
34. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
[TBL] [Abstract][Full Text] [Related]
37. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
[TBL] [Abstract][Full Text] [Related]
38. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
Han S; Ritzenthaler JD; Zheng Y; Roman J
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
[TBL] [Abstract][Full Text] [Related]
39. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
[TBL] [Abstract][Full Text] [Related]
40. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
